Alpha-9 Oncology nabs $175m Series C

Lightspeed Venture Partners and Ascenta Capital led the round.

23 October 2024•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals & Exits Briefs